Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
暂无分享,去创建一个
G. Scagliotti | F. Goldwasser | P. Woll | V. Hirsh | D. Henry | S. Vadhan-Raj | W. Willenbacher | V. Hungria | L. Costa | J. Prausová | A. Spencer | H. Yeh | H. Sleeboom | S. Jun | R. Dansey | R. von Moos | Q. Jiang | Jianming Wang